At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 49 enrolled
Drug / intervention
Marketed Denture Adhesive (Super Poligrip Max Seal) +1 morecombination
Likely dose
Marketed Denture Adhesive (Super Poligrip Max Seal) 1.6 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Single-Blind, Clinical Study to Assess Food Occlusion Efficacy of a Marketed Denture Adhesive in Healthy, Edentulous Subjects
In Brief
A Phase 4 clinical trial evaluating Marketed Denture Adhesive (Super Poligrip Max Seal) and No Adhesive for Denture Retention. Completed, enrolled 49 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the ability of a marketed denture adhesive to restrict food ingress underneath dentures during eating.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDenture Retention
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
First PostedOct 2018
Enrollment StartJan 2019
Primary CompletionJan 2019
TodayJul 2026
First PostedOct 17, 2018
Enrollment StartJan 7, 2019
Primary CompletionJan 24, 2019
TodayJul 2, 2026
Enrollment to primary: 17 daysPosted 7.7 years ago
Interventions
Marketed Denture Adhesive (Super Poligrip Max Seal)combination
The denture adhesive will be applied directly from the tubes. 1.6 g of adhesive per treatment will be applied to each participant's dentures. This dose will be split as 1.00±0.1 g for the maxillary and 0.6±0.1g for the mandibular dentures.
No Adhesiveother
No adhesive will be applied.